Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jessica Sage Little, M.D.

Concepts (69)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mycobacterium chelonae12022120.810 Why?
Bacteriophages220233820.790 Why?
Agammaglobulinemia120231740.780 Why?
Skin Diseases, Bacterial12022650.760 Why?
Opportunistic Infections120233750.720 Why?
Cytomegalovirus Infections220238390.690 Why?
Hematopoietic Stem Cell Transplantation4202457160.580 Why?
Epstein-Barr Virus Infections120236170.560 Why?
Respiratory Tract Infections1202310140.500 Why?
Lymphoma, Non-Hodgkin1202213760.480 Why?
Graft vs Host Disease2202430480.390 Why?
Intensive Care Units1202538000.370 Why?
Saccharomyces cerevisiae1202226820.370 Why?
Hospital Mortality1202553690.360 Why?
Health Personnel1202033820.270 Why?
B-Cell Maturation Antigen220231490.250 Why?
Candidiasis, Invasive12025260.240 Why?
Histoplasmosis12024640.230 Why?
Parvovirus B19, Human12024420.230 Why?
Herpesvirus 6, Human12024980.220 Why?
Immunotherapy, Adoptive2202315190.210 Why?
Physicians1202046070.200 Why?
Herpesvirus 8, Human120242560.200 Why?
Antigens, CD34120246560.200 Why?
Clarithromycin12022870.190 Why?
Mycobacterium120232520.190 Why?
Antifungal Agents220247610.180 Why?
Immunocompromised Host120248650.160 Why?
Antigens, CD19120224460.160 Why?
Cell Count1202218330.150 Why?
Treatment Failure1202426630.150 Why?
Herpesvirus 4, Human1202310820.150 Why?
Cyclophosphamide1202322270.150 Why?
Patient Care Management120203040.140 Why?
Retrospective Studies62025818920.130 Why?
Cystic Fibrosis1202312950.110 Why?
Adult620252238180.100 Why?
Tissue Donors1202223820.100 Why?
Critical Illness1202527540.100 Why?
Hematologic Neoplasms1202319070.100 Why?
Evoked Potentials, Visual120124200.080 Why?
Patient Positioning120123320.080 Why?
Humans1420257688870.080 Why?
Posture120129570.080 Why?
Anti-Bacterial Agents2202374720.070 Why?
Risk Factors22025749710.070 Why?
Transplantation, Homologous2202448350.060 Why?
Neoplasm Recurrence, Local1202394420.060 Why?
Histoplasma12024400.060 Why?
Visual Cortex1201211120.060 Why?
Parvoviridae Infections12024390.060 Why?
Models, Neurological1201217830.060 Why?
Incidence12022215450.060 Why?
Roseolovirus Infections12024500.060 Why?
Compassionate Use Trials12023500.050 Why?
Herpesviridae Infections120242690.050 Why?
Aged320251717900.040 Why?
Brain Mapping1201267400.030 Why?
Electroencephalography1201263180.030 Why?
Middle Aged320252237400.030 Why?
Pharmaceutical Preparations1202310880.030 Why?
Male420253652490.030 Why?
Antiviral Agents1202430690.020 Why?
Antibodies, Viral1202332160.020 Why?
Female320253974640.020 Why?
Immunoglobulin G1202345680.020 Why?
Young Adult22024601100.010 Why?
Computer Simulation1201262890.010 Why?
Adolescent12024892470.010 Why?
Little's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (51)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.